Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ)

References

Bellam, N. and Pasche, B. (2010). TGF-β signaling alterations and colon cancer. Canc. Treat Res. 155: 85–103, https://doi.org.10.1007/978-1-4419-6033-7_5.10.1007/978-1-4419-6033-7_5Search in Google Scholar

Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254, https://doi.org.10.1016/0003-2697(76)90527-3.10.1016/0003-2697(76)90527-3Search in Google Scholar

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., and Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancer in 185 countries. CA – Cancer J. Clin. 68: 394–424, https://doi.org.10.3322/caac.21492.10.3322/caac.21492Search in Google Scholar PubMed

Capitani, N., Lori, G., Paoli, P., Patrussi, L., Troilo, A., Baldari, C.T., Raugei, G., and D’Elios, M.M. (2019). LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy. Canc. Cell Int. 19, https://doi.org/10.1186/s12935-019-0786-1.10.1186/s12935-019-0786-1Search in Google Scholar PubMed PubMed Central

Chen, Q., Li, Y., Li, Z., Zhao, Q., and Fan, L. (2014). Overexpression of PTP1B in human colorectal cancer and its association with tumor progression and prognosis. J. Mol. Histol. 45: 153–159. https://doi.org/10.1007/s10735-013-9536-1.10.1007/s10735-013-9536-1Search in Google Scholar PubMed

Cristóbal, I., Manso, R., Rincón, R., Caramés, C., Zazo, S., del Pulgar, T.G., Cebrián, A., Madoz-Gúrpide, J., Rojo, F., and García-Foncillas, J. (2014). Phosphorylated protein phosphatase 2A determines poor out come in patients with metastatic colorectal cancer. Br. J. Canc. 111: 756–762, https://doi.org/10.1038/bjc.2014.376.10.1038/bjc.2014.376Search in Google Scholar PubMed PubMed Central

Dai, C., Zhang, X., Xie, D., Tang, P., Li, C., Zuo, Y., Jiang, B., and Xue, C. (2017). Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells. Oncotarget 8: 95810–95823, https://doi.org/10.18632/oncotarget.21336.10.18632/oncotarget.21336Search in Google Scholar PubMed PubMed Central

Faria, A.V.S., Andrade, S.S., Reijm, A.N., Spaander, M.C.W., de Maat, M.P.M., Peppelenbosch, M.P., Ferreira-Halder, C.V., and Fuhler, G.M. (2019). Targeting tyrosine phosphatases by 3-bromopyruvate overcomes hyperactivation of platelets from gastrointestinal cancer patients. J. Clin. Med. 8: 936, https://doi.org/10.3390/jcm8070936.10.3390/jcm8070936Search in Google Scholar PubMed PubMed Central

Ferreira-Halder, C.V., Piatto Clerici, S.P., Faria, A.V.S., Oliveira, P.F.S., Cordeiro, H.G., and Akagi, E. (2019). Protein tyrosine phosphatases in tumor progression and metastasis: promoter or protection?. In: Ahmed, L. (Ed.), Tumor Progression and Metastasis. IntechOpen, London, UK, pp. 1–21, https://doi.org/10.5772/intechopen.87963.10.5772/intechopen.87963Search in Google Scholar

Ferreira, P.A., Ruela de Sousa, R.R., Queiroz, K.C.S., Souza, A. C.S., Milani, R., Pilli, R.A, Peppelenbosch, M.P., Hertog, J., and Ferreira, C.V. (2012). Knocking down low molecular weight protein tyrosine phosphatase (LMW-PTP). Reverts chemoresistance through inactivation of Src and Bcr-Abl proteins. PLoS One 7: e44312, https://doi.org/10.1371/journal.pone.0044312.10.1371/journal.pone.0044312Search in Google Scholar PubMed PubMed Central

Garbe, C., and Eigentler, T.K. (2018). Vemurafenib. Recent Results Canc. Res. 211: 77–89, https://doi.org/10.1007/978-3-319-91442-8_6.10.1007/978-3-319-91442-8_6Search in Google Scholar PubMed

Gharwan, H. and Groninger, H. (2016). Kinase inhibitors and monoclonal antibodies in oncology: clinical implications. Nat. Rev. Clin. Oncol. 13: 209–227, https://doi.org/10.1038/nrclinonc.2015.213.10.1038/nrclinonc.2015.213Search in Google Scholar PubMed

Gschwind, A., Fischer, O.M., and Ullrich, A. (2004). The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 4: 361–370, https://doi.org/10.1038/nrc1360.10.1038/nrc1360Search in Google Scholar PubMed

Hanahan, D. and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144: 646–674, https://doi.org/10.1016/j.cell.2011.02.013.10.1016/j.cell.2011.02.013Search in Google Scholar PubMed

Hoekstra, E., Das, A.M., Swets, M., Cao, W., van der Woude, C.J., Bruno, M.J., Peppelenbosch, M.P., Kuppen, P.J., Ten Hagen, T.L., and Fuhler, G.M. (2016). Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome. Oncotarget 7: 21922–21938, https://doi.org/10.18632/oncotarget.7829.10.18632/oncotarget.7829Search in Google Scholar PubMed PubMed Central

Hoekstra, E., Kodach, L.L., Das, A.M., Ruela-de-Sousa, R.R., Ferreira, C.V., Hardwick, J.C., van der Woude, C.J., Peppelenbosch, M.P., Ten Hagen, T.L., and Fuhler, G.M. (2015). Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer. Oncotarget 6: 8300–8312, https://doi.org/10.18632/oncotarget.3224.10.18632/oncotarget.3224Search in Google Scholar PubMed PubMed Central

Islam, S.U., Ahmed, M.B., Lee, S.J., Shehzad, A., Sonn, J.K., Kwon, O.S., and Lee, Y.S. (2018). PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin. Exp. Cell Res. 369: 158–165, https://doi.org/10.1016/j.yexcr.2018.05.018.10.1016/j.yexcr.2018.05.018Search in Google Scholar PubMed

Lai, Z., Yan, Z., Chen, W., Peng, J., Feng, J., Li, Q., Jin, Y., and Lin, J. (2017). Hedyotis diffusa Willd suppresses metastasis in 5-fluorouracil-resistant colorectal cancer cells by regulating the TGF-β signaling pathway. Mol. Med. Rep. 16: 7752–7758, https://doi.org/10.3892/mmr.2017.7500.10.3892/mmr.2017.7500Search in Google Scholar PubMed

Li, B., Huang, M., Liu, M., Wen, S., and Sun, F. (2017). MicroRNA-329 serves a tumor suppressive role in colorectal cancer by directly targeting transforming growth factor beta-1. Mol. Med. Rep. 16: 3825–3832.10.3892/mmr.2017.7077Search in Google Scholar PubMed

Lori, G., Paoli, P., Caselli, A., Cirri, P., Marzocchini, R., Mangoni, M., Talamonti, C., Livi, L., and Raugei, G. (2018). Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo-and radiotherapy. Cancer Med. 7: 1933–1943, https://doi.org/10.1002/cam4.1435.10.1002/cam4.1435Search in Google Scholar PubMed PubMed Central

Marin, J.J., Sanchez de Medina, F., Castaño, B., Bujanda, L., Romero, M.R., Martinez-Augustin, O., Moral-Avila, R.D., and Briz, O. (2012). Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. Drug. Metab. Rev. 44: 148–172, https://doi.org/10.3109/03602532.2011.638303.10.3109/03602532.2011.638303Search in Google Scholar PubMed

McCubrey, J.A., Steelman, L.S., Chappell, W.H., Abrams, S.L., Wong, E.W., Chang, F., Lehmann, B., Terrian, D.M., Milella, M., Tafuri, A., and Stivala, F. (2007). Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta Mol. Cell Res. 1773: 1263–1284, https://doi.org/10.1016/j.bbamcr.2006.10.001.10.1016/j.bbamcr.2006.10.001Search in Google Scholar PubMed PubMed Central

Reithmeier, A., Panizza, E., Krumpel, M., Orre, L.M., Branca, R.M.M., Lehtiö, J., Ek-Rylander, B., and Andersson, G. (2017). Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells. BMC Cancer 17, https://doi.org/10.1186/s12885-017-3616-7.10.1186/s12885-017-3616-7Search in Google Scholar PubMed PubMed Central

Rocha, L.S. and Riechelmann, R.P. (2018). Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges. Clinics (Sao Paulo) 73, https://doi.org/10.6061/clinics/2018/e542s.10.6061/clinics/2018/e542sSearch in Google Scholar PubMed PubMed Central

Ruela-de-Sousa, R.R., Hoekstra, E., Hoogland, A.M., Souza Queiroz, K.C., Peppelenbosch, M.P., Stubbs, A.P., Pelizzaro-Rocha, K., van Leenders, G.J.L.H., Jenster, G., Aoyama, H., and Ferreira, C.V. (2016). Low-molecular-weight protein tyrosine phosphatase predicts prostate cancer outcome by increasing the metastatic potential. Eur. Urol. 69: 710–719, https://doi.org/10.1016/j.eururo.2015.06.040.10.1016/j.eururo.2015.06.040Search in Google Scholar PubMed

Sakoff, J.A., Howitt, I.J., Ackland, S.P., and McCluskey, A. (2004). Serine/threonine protein phosphatase inhibition enhances the effect of thymidilate synthase inhibition. Canc. Chemother. Pharmacol. 53: 225–232, https://doi.org/10.1007/s00280-003-0730-9.10.1007/s00280-003-0730-9Search in Google Scholar PubMed

Schreck, R. and Rapp, U.R. (2006). Raf Kinases: oncogenesis and drug discovery. Int. J. Cancer 119: 2261–2271, https://doi.org/10.1002/ijc.22144.10.1002/ijc.22144Search in Google Scholar PubMed

Siegel, R., Desantis, C., and Jemal, A. (2014). Colorectal cancer statistics, 2014. Ca - Cancer J. Clin. 64: 104–17, https://doi.org/10.3322/caac.21220.10.3322/caac.21220Search in Google Scholar PubMed

Spender, L.C., Ferguson, G.J., Liu, S., Cui, C., Girotti, M.R., Sibbet, G., Higgs, E.B., Shuttleworth, M.K., Hamilton, T., Lorigan, P., and Weller, M. (2016). Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells. Oncotarget 7: 81995–82012, https://doi.org/10.18632/oncotarget.13226.10.18632/oncotarget.13226Search in Google Scholar PubMed PubMed Central

Sun, C., Wang, F.J., Zhang, H.G., Xu, X.Z., Jia, R.C., Yao, L., and Qiao, P.F. (2017). miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway. World J. Gastroenterol. 23: 1816–1827, https://doi.org/10.3748/wjg.v23.i10.1816.10.3748/wjg.v23.i10.1816Search in Google Scholar PubMed PubMed Central

Sun, F., Yu, M., Yu, J., Liu, Z., Zhou, X., Liu, Y., Ge, X., Gao, H., Li, M., Jiang, X., and Liu, S. (2018). miR-338-3p functions as a tumor supressor in gastric cancer by targeting PTP1B. Cell Death Dis. 9, https://doi.org/10.1038/s41419-018-0611-0.10.1038/s41419-018-0611-0Search in Google Scholar PubMed PubMed Central

Tang, Y.A., Chen, Y.F., Bao, Y., Mahara, S., Yatim, S.M.J.M., Oguz, G., Lee, P.L., Feng, M., Cai, Y., Tan, E.Y., and Fong, S.S. (2018). Hypoxic tumor microenvironment activates GlI2 via HIF-1α and TGF- β2 to promote chemoresistance in colorectal cancer. Proc. Natl. Acad. Sci. USA 115: 5990–5999, https://doi.org/10.1073/pnas.1801348115.10.1073/pnas.1801348115Search in Google Scholar PubMed PubMed Central

Teng, H.W., Hung, M.H., Chen, L.J., Chang, M.J., Hsieh, F.S., Tsai, M.H., Huang, J.W., Lin, C.L., Tseng, H.W., Kuo, Z.K., and Jiang, J.K. (2017). Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma. Sci. Rep. 6, https://doi.org/10.1038/srep45612.10.1038/srep45612Search in Google Scholar PubMed PubMed Central

Tsai, J., Lee, J.T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N.K., and Sproesser, K. (2008). Discovery of a selective inhibitor of oncogenic B-Raf Kinase with potent antimelanoma activity. Proc. Natl. Acad. Sci. USA 105: 3041–3046, https://doi.org/10.1073/pnas.0711741105.10.1073/pnas.0711741105Search in Google Scholar PubMed PubMed Central

Tsamandas, A.C., Kardamakis, D., Ravazoula, P., Zolota, V., Salakou, S., Tepetes, K., Kalogeropoulou, C., Tsota, I., Kourelis, T., Makatsoris, T., and Karavias, D. (2004). The potential role of TGF beta1, TGF beta 2 e TGF beta 3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival. Strahlenther. Onkol. 180: 201–208 https://doi.org/10.1007/s00066-004-1149-x.10.1007/s00066-004-1149-xSearch in Google Scholar PubMed

Wang, P., Bai, Y., Song, B., Wang, Y., Liu, D., Lai, Y., Bi, X., and Yuan, Z. (2011). PP1A-mediated dephosphorylation positively regulates YAP2 activity. PloS One 6: 1–8, https://doi.org/10.1371/journal.pone.0024288.10.1371/journal.pone.0024288Search in Google Scholar PubMed PubMed Central

Wei, L., Wang, X., Lv, L., Zheng, Y., Zhang, N., and Yang, M. (2019). The emerging role of noncoding RNAs in colorectal cancer chemoresistance. Cell. Oncol. (Dordr.) 42: 757–768, https://doi.org/10.1007/s13402-019-00466-8.10.1007/s13402-019-00466-8Search in Google Scholar PubMed